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The most affected cell types in cerebellar ataxias are the cerebellar neurons, 
which are not readily accessible for cellular and molecular investigation. Pluripotent 
stem cell (PSC) technology has emerged as an important tool for generating diverse 
types of neurons, which are used in order to better understand the human nervous 
system development and pathologies. In this chapter, the strategies for the dif-
ferentiation of human PSCs toward cerebellar neurons are overviewed, followed 
by an outlook of their further optimization and diversification by implementing 
the knowledge from cerebellar development and new cell culture approaches. The 
optimization stategies are based on the recent progress made in defining the cell 
populations in mature and developing mouse and human cerebellum. The cellular 
phenotypes and organization in mouse and human cerebellum are briefly presented, 
followed by an overview of our current knowledge about their development, which 
includes pattering, proliferation, neurogenesis, gliogenesis, migration, connectivity 
and maturation. To date, however, relatively few studies have used induced PSCs 
(iPSCs) to model cerebellar ataxias and even fewer have looked directly to cerebel-
lar neurons. The reported iPSC-derived in vitro models for cerebellar ataxias are 
reviewed, followed by an outlook of how to improve these models by generating and 
exporing the cerebellar neurons.
Keywords: cerebellar ataxias, iPSC-derived cellular models, cerebellar neurogenesis, 
Purkinje cells, cerebellar organoids
1. Introduction
Cerebellar ataxias constitute a very heterogeneous group of diseases in which 
the motor incoordination is caused by the dysfunction and degeneration of the 
cerebellar neurons. Although different causative genes or toxins have been identi-
fied and several pathological pathways have been investigated, the treatments 
for these conditions are still largely palliative. Therefore, it is an urgent need for 
disease-relevant cellular models for studying disease progression and screening for 
potential therapies.
The rapid development in the field of induced pluripotent stem cell (iPSC) 
technology offers the opportunity to combine the genetic authenticity of the 
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patient-derived cellular models with the disease-relevant cell types. Human iPSCs 
have been generated from a wide variety of easily accessible tissues, including skin 
and blood cells, using methods which nowadays are safer because they avoid the 
genomic integration of the viral vectors containing reprogramming factors. The 
potential of iPSCs to differentiate into any cell type of the body was previously 
explored by the studies with mouse and human embryonic stem cells (ESCs), which 
are blastocyst-derived pluripotent populations. Both iPSCs and ESCs may offer 
direct access to study the cells making the nervous system, but straightforth for 
disease models are the neurons differentiated from iPSCs, generated from patients 
with a variety of neurologic or neurodegenerative conditions [1, 2].
Although significant advances have been made, most of the protocols for the 
differentiation of human PSCs into neurons yield cellular populations which can 
only partially mirror the functional characteristics detected in vivo. In addition, 
most of the available neuronal characterization comes from the studies in rodents 
and we still know little about the phenotypes that the human neurons have in dif-
ferent stages of their development or degeneration. Nowadays, only few protocols 
generate efficiently specific neuronal classes, such as the midbrain dopaminergic 
neurons or the cortical neurons, while for the most neuronal types in the human 
brain, including the neurons of the cerebellum, the efficiency of the protocols is 
much lower and additional cell selection methods are required.
As it happened for the generation of other human neural or non-neural cells and 
especially for the generation of the cerebral cells (reviewed in [3, 4]), the improve-
ments in the generation of cerebellar neurons will definitely come from a better 
knowledge of the human cerebellum and its developmental pathways.
The human adult cerebellum is the second largest brain part (after the cerebral 
cortex) and contains around 80 billion neurons (which represents four times more 
neurons than in the cerebral cortex) [5–8]. These neurons contribute to the complex 
cerebellar functions, including the control of movements for performing fine-
tuning and coordination [9, 10], as well as of cognitive and emotional processes  
[11, 12]. The morphological and functional organization in the cerebellum, inten-
sively investigated in rodents, is highly conserved across vertebrates [13]. Both 
human and mouse cerebella contain two lateral hemispheres connected by a region 
named vermis. The lateral hemispheres are subdivided into lobes and lobules and, 
together with vermis, covered by a uniformly pliated gray matter forming the 
cerebellar cortex. Cerebellar neurons have their cell bodies (somas) located in the 
cerebellar cortex and in the nuclei situated inside the white matter of each cerebel-
lar hemisphere, called deep cerebellar nuclei (DCN). There are four distinctive 
DCN in mouse (dentate, fastigial, emboliform and globose), while the last two are 
fused as the interposed nucleus in human [10, 13].
The higher number of lobules in humans makes the cerebellar cortex more 
expanded relative to mice; in spite of the increase in size, both the volume of the 
cerebellum as a percentage of the total brain and the ratio of the number of neurons 
in the cerebellum to the cerebral cortex is remarkably constant across mammalian 
species, pointing to the concomitant increase of the cerebellum and the cerebral 
cortex in humans [6, 8, 14–17].
The morphological organization of the adult cerebellum is schematically 
presented in Figure 1. The neurons located in the cerebellar cortex form three 
laminar structures laying between the internal white matter and the external pia 
mater: the granular layer (GL, named also the inner GL), the Purkinje layer (PL) 
and the molecular layer (ML). The GL contains the densely packed granule cells, 
which are the most abundant cell type in cerebellum and in the whole brain, as 
well as few other cells, such as Golgi cells (with different subtypes, such as Lugano, 
globular and candelabrum) and unipolar brush cells. PL is a narrow middle zone 
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that contains the large cell bodies of the Purkinje cells, together with the cell bodies 
of a special type of glial cells named Bergmann glia. The ML contains mainly cell 
projections, but also a few entire neurons such as the basket cells located near the 
PL and stellate cells located near the pia mater.
In addition to the shape and location of their cell bodies, the cerebellar neurons 
are characterized by other intrinsic properties included in their neurochemical 
profiles (neurotransmitters, associated neuropeptides and receptors), electrophysi-
ological profiles and, in the recent years, in high-throughput transcriptional finger-
prints. Based on the neurotransmitters used for synaptic communication,  cerebellar 
neurons are set into two main classes: excitatory neurons, which release glutamate, 
and inhibitory neurons, which release mainly γ-aminobutyric acid (GABA). 
Excitatory neurons are situated in the cerebellar cortex (granule and unipolar brush 
cells) and in the DCN. Inhibitory neurons are localized also in the cerebellar cortex 
(Purkinje cells, Golgi cells, basket and stellate cells) and in the DCN (Figure 1).
Figure 1. 
Cellular composition and organization in the adult cerebellum. The cerebellum contains, from exterior to 
interior, the cerebellar cortex with 3 layers, the molecular layer (ML), the Purkinje layer (PL) and the 
granular layer (GL), and the deep cerebellar nuclei (DCN) situated in the white matter (WM). Excitatory 
(red-orange) and inhibitory (green) neurons are located in the cortex (granule cells (GC), unipolar brush 
cells (UBC), Purkinje cells (PC), Golgi (G), basket (B) and stellate (S) cells) and in the DCN (E-DCN and 
I-DCN). GC and UBC receive external afferents via mossy fiber, while E-DCN via both mossy fibers and 
climbing fibers. PC receive external afferents via climbing fibers and internal afferents via parallel fibers, 
sending efferents to DCN. BG: Bergmann glia (gray).
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Regarding tissue architecture and connectivity, the cerebellar neurons are 
arranged as repeating units in a highly regular manner, relatively identical in all 
areas of the cerebellar cortex. Granule cells and excitatory neurons in DCN are pro-
jection neurons, while inhibitory neurons in the cortex (Golgi cells, stellate cells and 
basket cells) and DCN, and the unipolar brush cells are interneurons. Granule cells 
receive excitatory signals from neurons of the brainstem or spinal cord, mainly with 
a station in the middle or inferior cerebellar peduncle, via the mossy fiber afferents. 
The information from ~25 million mossy fibers is dispersed to ∼50 billion granule 
cells, but each dendrite apparently synapses with a single mossy fiber, in this way 
promoting combinatorial encoding and enhanced processing of sensory input to the 
cerebellum. Unipolar brush cells receive sensorimotor signals via mossy fibers, each 
cell forming a specialized giant synaptic junction with a single mossy fiber terminal. 
Their axons branch locally within the GL, where an intrinsic system superimposes 
on the canonical extrinsic mossy fiber system (reviewed in [15]).
The axons of granule cells project to the ML, where they form the parallel fibers, 
which intercept the dendrites of Purkinje cells at right angles. There are ~200  granule 
cells per Purkinje cell in mice, while in humans there are 3000 granule cells per 
Purkinje cell [8]. Purkinje cell bodies form a monolayer in the middle of PL, each 
neuron sending a monoplane-oriented expansive dendritic tree with thousands of 
little spines into the ML, while its axon projects towards and connects with one neuron 
in the DCN. In addition to the inputs from granule cells, each Purkinje cell receives 
excitatory signals from climbing fibers arising from the inferior olive neurons in the 
medulla (which receives sensory information from the cortex). Purkinje cells convey 
the results of the analysis of afferent information to the excitatory neurons in DCN, 
which form the main cerebellar output. Each excitatory neuron in DCN receives inputs 
from several Purkinje cells, but also inputs from the spinocerebellar tract via the mossy 
fibers and from the inferior olive via the climbing fibers. Excitatory neurons in DCN 
send projections back to the brainstem and to motor cortex via the thalamus [18, 19].
Remarkably, Purkinje cells can exhibit two distinct types of action potential, 
with simple and complex spikes. The simple spikes represent an autonomous 
pacemaker activity, with very little variability between spiking intervals, firing 
in absence of synaptic inputs. The simple spikes can be modulated by inputs from 
mossy fiber via the parralel fibers. Inhibitory interneurons in the ML, i.e. the 
stellate and basket cells, also influence circuit topography by making synapses with 
the dendritic tree and modulating the activity level of Purkinje cells. Additionally, 
Purkinje cells can evoke complex climbing fiber inputs. Integration of the inputs 
from climbing fibers and parralel fibers in Purkinje cells generates a unique form of 
heterosynaptic plasticity, that has been shown to underlie the motor learning [18, 
20, 21]. In line with the recent multimodal characterization of the cerebral cortical 
neurons [22], a deeper investigation of the electrical profiles in human cerebellum is 
expected from the new Patch-seq techniques [23, 24].
A more extensive neuronal characterization was recently performed by high 
throughput sequencing, including single-cell sequencing for mouse and human 
 cerebellar tissue [25, 26]. In spite of their quite regular morphology, the cerebellar 
neurons in each subclass appear as a heterogeneous population, different subsets 
being defined by several molecular cues, including co-neurotransmitters (e.g. 
glycine) and neuromodulators (e.g. calbindin, parvalbumin). Markers of some 
subclasses are related to the position in the cerebellar areas (reviewed in [27]). In 
addition, a comparative high throughput analysis of mouse versus human  cerebellar 
cells using single cell-RNA sequencing showed that several genes are expressed 
in human but not in mouse Purkinje cells and confirmed at protein level the 
 expression of novel and specific human Purkinje cell markers, in line with the data 
from the cerebral cortex [28, 29].
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Recent progress in genetic technologies has significantly clarified how the cer-
ebellar cells and their circuits are formed in model organisms, especially in mouse 
[30–33]. Remarkable advances were made not only in defining of the molecular 
phenotypes and the differentiation pathways for most of the neural progenitors, 
but also in understanding of how these synchronize for forming neuronal circuits. 
Purkinje cells have major roles also during development [34]. They orchestrate the 
long lasting neurogenesis of the granule cells, the most abundant local excitatory 
neurons, and the maturation of the local inhibitory neurons, which reciprocally 
respond by helping in their own maturation.
The human-specific morphological and functional attributes were intensively 
studied over the last two decades, including for the development of the cerebellum. 
Mouse mutants for different genes related to developmental diseases affecting the 
cerebellum in humans demonstrated a considerable evolutionary conservation of 
the molecular programs across species, but also revealed some human-specific dif-
ferences. Recent investigations of the developing human cerebellum have empha-
sized some differences in the organization of the cerebellar progenitor pools. Other 
human specific differences have been outlined by the single-cell sequencing of dif-
ferent brain cells, including cells in the cerebellum. These high throughput results 
point out that we still have much to learn about the human cerebellar development, 
composition and functions.
To what extent can or could the cellular diversity in the adult human cerebellum, 
and, in the same time, the spatial precision in its organization in vivo be reproduced 
by the PSC-related differentiation protocols? Which would be a proper human 
model for cerebellum development and cerebellar diseases?
The reported strategies for the differentiation of human PSCs toward cerebel-
lar neurons, especially toward Purkinje cells, are reviewed in this chaper, followed 
by an outlook of their further optimization and diversification by implementing 
the knowledge from cerebellar development and new cell culture approaches. 
This outlook incudes an overview of the recent progress made in defining the cell 
populations in developing mouse and human cerebellum, followed by our cur-
rent knowledge about their development, which includes pattering, proliferation, 
neurogenesis, gliogenesis, migration, connectivity and maturation. This knowledge 
is also the basis for the establishment and optimization of the PSC-derived models 
for cerebellar ataxias. An overview of the reported in vitro patient-derived iPSC 
approaches for modeling cerebellar ataxias is presented, followed by an outlook of 
some challenges that remains to be overcome.
2. Differentiation of pluripotent stem cells toward cerebellar neurons
Over the past 20 years, human PSCs, including the ESCs and the iPSCs [35–38], 
have revolutionized the research on human development and diseases, particularly 
for the nervous system. Considerable progress has been made in converting  
human PSC into different types of neural progenitors, from which some continued 
to differentiate toward different classes of neurons, in vitro or after 
xenotransplantation.
Most of the reported human PSC-based protocols are an adaptation of the 
protocols that were previously developed for mouse ESCs, which reflect, to a 
various extent, different stages of neural differentiation in mouse embryo. On this 
line, the differentiation of the human PSCs is expected to reflect different stages 
of neural differentiation in human embryonic and fetal stages. Remarkably, recent 
data have demonstrated that several protocols starting from human PSCs produced 
authentic neurons and structured brain-like tissues, including the cerebral cortex, 
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the most complex structure in the human brain. However, many questions remain 
about the extent to which the relative simplistic in vitro settings could reproduce the 
high complexity of the adult brain structures, both in cell diversity and connectivity 
(reviewed in [3, 39]).
For the neurons making the human cerebellum, the progress of in vitro dif-
ferentiation protocols was a lot slower comparing to other neuronal populations, 
such as the spinal cord motoneurons, midbrain dopaminergic neurons, and gluta-
matergic and GABAergic cortical neurons, between many others. The main reason 
is the complexity of the cerebellar development, which was only partially and only 
recently deciphered (overviewed in the next section), while the developmental 
mechanisms for the spinal cord, midbrain and cerebral cortex were much faster and 
deeper investigated [40–43].
Increasing understanding of cerebellar development has allowed the elaboration 
of several protocols in the last years, which made the production of some classes 
of cerebellar neurons possible, with increasing efficiencies. These protocols were 
implemented in 2D and 3D cell cultures, or in their combination. As for other brain 
regions, the differentiation protocols include “directed” steps, meaning controlled 
differentiation by using extrinsic manipulation approaches, but also steps in which 
the differentiation advances spontaneously. Most of the protocols use morphogens/
growth factors or small molecules with similar functions, which are sequentially 
administered to mimic the environment in vivo.
Two early studies implemented the mouse ESCs differentiation into cerebel-
lar neurons, using different approaches [44, 45], which were followed by several 
protocols aimed to increase their efficiency. Su et al. [45] used non-adherent ESC 
cell clusters in serum-free medium supplemented with fibroblast growth factor 2 
(FGF2) and insulin. The cellular spheroids, named serum-free embryoid bodies 
(SFEB, even though they contained mainly undifferentiated cells in this stage), 
gradually differentiated into more complex 3D cell aggregates containing a mixture 
of progenitor cells and neurons, which included some granule cell progenitors and 
few neurons expressing early Purkinje cell markers. Following the same conditions, 
Muguruma et al. [46] showed that the FGF2-treated neural progenitors presented 
a broad fate, but some cells organized in tissue-like structures resembling the 
cerebellum origin in the embryo. These 3D cell aggregates further formed brain 
organoids, which contained some areas organized as a primitive cerebellar tissue. 
When cyclopamine, a sonic hedgehog (SHH) antagonist, was added to block the 
spontaneous ventralization, the proportion of cerebellar cells was increased, includ-
ing 35–42% Purkinje cell progenitors by day 11 of ESC differentiation. Additionally, 
this study introduced the selection of the cerebellar progenitor cells, addressing to a 
cell-surface marker expressed in this population (Kirrel2/Neph3). The selected cells 
survived and integrated into the mouse cerebellum following in utero transplanta-
tion at embryonic day (e) 15.5, but their surviving and differentiation into Purkinje 
cells in vitro was possible only in co-culture with dissociated mouse postnatal 
cerebellar cells [47]. Following the same protocol, Tao et al. [48] showed that the 
cerebellar organotypic slices prepared from mice at postnatal day (p) 6–8 supply an 
appropriate trophic environment for the differentiation and maturation of ESC-
derived Purkinje cells. Remarkably, after 28 days in co-culture, they showed the 
same characteristics as the neonatal Purkinje cells.
Salero and Hatten [44] succeeded in generating mouse ESC-derived granule 
cells at a relatively high efficiency by implementing a protocol in 2D culture based 
on step-related treatments with different morphogens. FGF8, WNT1 and retinoic 
acid (RA) were used in the first step, while bone morphogenic proteins (BMPs) 
were used in the next step to obtain the granule cell progenitors, which were next 
proliferated with SHH and Jagged1 and showed markers expressed in GL in vivo. 
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Again, for differentiation and maturation, granule cell progenitors were co-cul-
tured with either postnatal mouse cerebellar neurons or glial-conditioned medium 
and the resulted neurons resembled the neonatal counterparts.
The pioneering studies of mouse ESC cerebellar differentiation were next 
translated to human PSCs and subsequently refined (Table 1). The protocol of 
Muguruma et al. [46] in 3D culture was applied to human ESC and iPSCs [49, 50, 
52]. Human progenitor cells self-organized in polarized neuroepithelium containing 
around 10% KIRELL2+ cells after 20 days. Muguruma et al. [50] also refined this 
protocol and followed a long-term ESC differentiation in 3D culture, an approach 
which resembled the first generation of human brain organoids. They found that 
the dorsal hindbrain patterning is more efficient for human cells without cyclo-
pamine. Sequential addition of FGF19 and stromal cell-derived factor 1 (SDF1) 
generated approximately 28% KIRREL2+ cells (representing the progenitors of the 
cerebellar inhibitory neurons) and 18% ATOH1+ cells (representing the progeni-






























































































































Reported protocols for the differentiation of human PSCs toward cerebellar neurons.
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KIRREL2+ cells were subsequently selected by fluorescence activated cell sorting 
(FACS) and differentiated into Purkinje cells in co-culture with murine granule cell 
progenitors. The in vitro differentiation of the KIRREL2+ cells for 10 days generated 
~45% Purkinje cell progenitors.
Other approaches aimed to increase the proportion of human ESC-derived 
cerebellar cells by applying the hindbrain patterning conditions tested for mouse 
ESCs [44]. Erceg et al. [53, 55] treated human ESCs aggregates with FGF8b and RA, 
followed by a manual selection of the neuroepithelial cells organized in polarized 
structures. This procedure yielded, after further differentiation, a heterogeneous 
population expressing markers of granule cells, Purkinje cells and glial cells. In a 
more directed differentiation approach, Sundberg et al. [54] used the WNT agonist 
CHIR99021, FGF8b and FGF2 for pattering the neuroepithelial cells resulted from 
the parallel neural induction of human ESCs with dual-SMAD inhibition [56]. The 
patterned progenitors gradually express the hindbrain, cerebellar and Purkinje cell 
progenitor markers, such as EN1/2, GBX2, PTF1a, KIRREL2 and SKOR2. Between 
days 24 and 48 of differentiation, markers of GABAergic phenotype and markers 
of immature Purkinje cells, such as PCP2, were detected. In order to enrich for the 
Purkinje cell population, instead of the previously used cell sorting for KIRELL2, 
Sundberg et al. [54] implemented the THY1+ cell selection, a method previously 
used to purify mouse Purkinje cells from primary cerebellar cultures [57]. The 
sorted THY1+ cells further matured into Purkinje cells expressing the early Purkinje 
cells marker PCP2 (or L7). The same team further optimized the directed differen-
tiation protocol [28], by quantifying the effect of patterning molecules on directing 
the cerebellar cell phenotypes. They found that the combination of the GSK3 inhibi-
tor CHIR99021 (1.5 μM) for 4 days with FGF8b (100 ng/ml) between days 5 and 
12 of differentiation generated the highest proportion of Purkinje cell progenitors. 
From days 12 to 24, neural cell expressing the cerebellar marker KIRREL2 gave rise 
to increasing numbers of adjacently located cells expressing Purkinje cell markers. 
As early as day 35 of differentiation, subpopulations of iPSC-derived cells expressed 
markers of the primary cerebellar progenitor cells. The postmitotic Purkinje cell 
marker PCP2 was observed starting from day 18 onward. Flow cytometry analysis 
showed that ∼23% of cells expressed PCP2 at day 24 of differentiation. A changing 
element of this protocol was the selection of the immature human PSC-derived 
Purkinje cells in two steps, a negative selection by GD3 immunopanning and a posi-
tive selection by magnetic cell sorting (MACS) with NCAM antibodies [28].
As for the mouse cerebellar neurons, the conditions used for the in vitro matu-
ration of the Purkinje cells and granule cells generated from human PSC were 
undefined, based on co-culture with different cerebellar tissue-derived popula-
tions (Table 1). The maturation into functional Purkinje neurons has so far been 
achieved in undefined conditions by co-culturing with either cerebellar granule 
cell precursors isolated from murine embryos [50–52], or with fetal or postnatal 
cerebellar organotypic slices [48, 49]. A protocol adapted from Muguruma et al. 
[50] eliminated the KIRREL2+ cell sorting and employed the differentiation of 
human cells in co-culture with e18.5 mouse cerebellar progenitors [52]. Again, 
markers of the cerebellar proliferative zones were detected at early times of dif-
ferentiation and around 10% Calbindin+ Purkinje cells were detected from day 50 
onward. Following long-term co-culture (up to 150 days), these neurons expressed 
the Purkinje cell markers L7, Calbindin, Aldolase C and LHX5 [50]. In the study 
of Sundberg et al. [54], the selected Purkinje cells were co-cultured with mouse 
cerebellar glia and then with mouse granule cells. With this methodology, human 
PSC-derived Purkinje cells formed synapses with mouse granule cells and had more 
differentiated morphologies. However, significant electrophysiological activity, 
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comparable with that of Purkinje cells in vivo of the iPSC-derived neurons, was 
observed only following co-culture with human fetal cerebellar slices [49].
3.  Strategies for the optimization of the human PSC-derived cerebellar 
cultures
Even though the reported protocols have advanced in the generation of cer-
ebellar neuron from human PSCs, they still need a lot of optimization in order to 
generate homogeneous population of cerebellar neurons in 2D cultures or cerebel-
lar tissue-like aggregated in 3D cultures. Looking at the previous optimizated 
protocols for generating other neuronal populations, such as the midbrain neurons, 
the cortical neurons or the cortical organoids, it is relevant to follow again the steps 
which were gradually applied in order to achieve the efficiency and complexity 
they offer today (reviewed in [3, 4]). Following this aim, here the development 
principles of the cerebellar neurons are overviewed, from progenitor specification 
to neuronal assembles, followed by an outlook of how these principles could be 
applied for the optimization of the protocols generating cerebellar neurons from 
human PSCs.
During early embryo development, the human neural tube is formed by the 
folding of a sheet of neuroepithelium and is progressively closed and regionalized 
under the control of temporally and spatially coordinated gradients of morphogens 
secreted by organizer centers. At the end of the neurula stage, corresponding to 
embryonic day (E) 28, the neural tube is entirely closed and contains, from anterior 
to posterior, the three primary brain vesicles (forebrain, midbrain and hindbrain) 
and the spinal cord. Soon after the definition of the midbrain-hindbrain boundary 
(MHB), cerebellum starts to form at the most anterior and dorsal hindbrain territory. 
In humans, the cerebellar development is highly protracted, extending from E30 to 
the end of the second postnatal year. In mice, cerebellum almost completes over a 
period of around one month, starting from embryonic day (e) 9 and including the 
first three postnatal weeks (reviewed in [15, 58–60] (Figure 2). However, as for the 
whole brain, the mechanisms of cell differentiation and histogenesis in cerebellum 
are mainly conserved in mammals. While the development of the mouse cerebellum 
was intensively studied [15, 30, 32–34, 58, 61–65], the embryonic and fetal stages 
in human cerebellar development were only recently described in details [13, 16, 
59, 60]. Notably, as for the other parts of the human brain, the embryonic and fetal 
stages of development are not available for cellular and functional studies, and their 
histological and clinical images represent only snapshots in time for one individual. 
Conversely, developmental time-course experiments in mice can be conducted on 
multiple mice of identical genotypes. These studies revealed that the ontogenesis of 
all neurons and glial cells in the nervous system, including the ones in the cerebel-
lum, follows the same steps of (1) patterning and specification of the progenitor 
cells, (2) neurogenesis/gliogenesis and (3) migration, histogenesis, formation of 
the neuronal circuits and neuronal maturation (reviewed in [15, 27, 58, 61, 66, 67]). 
However, in contrast to other CNS areas, including the cerebral cortex, in which 
gliogenesis follows neurogenesis [68, 69], glia generation in cerebellum parallels 
or precedes the long-lasting generation of the granule cells and inhibitory neurons 
[15, 30, 32, 65, 68]. Even though the main developmental programs are conserved 
from mice to humans, some important specie-specific differences responsible for 
the expansion of the human cerebellum have been recently identified [59, 60]. In the 
following brief presentation, the main morphological, cellular and molecular events 
in mouse are complemented with the available information in human.
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3.1 Patterning and specification of the cerebellar progenitor cells
Several studies in mouse showed that all cerebellar neurons and glial cells 
originate from the hindbrain region corresponding to the dorsal (or alar) part (or 
plate) of the first rhombomere (r1) [30, 70]. The anterior limit of the cerebellum 
is defined by the MHB, named also isthmus, where an organizer center, named the 
isthmus organizer (IsO), forms early in development and has a major role in the 
anterior/posterior (A/P) patterning of the midbrain and hindbrain. IsO formation 
is preceded by a series of pattering events that start in the forming neural plate, 
where two transcription factors, Otx2 (Orthodenticle Homeobox 2) and Gbx2 
(Gastrulation Brain Homeobox 2) define the primitive anterior and posterior 
domains, respectively [71]. They are further co-expressed in early IsO and then 
differentially express in the midbrain and hindbrain domains [72]. WNT signaling 
has a main role in the A/P patterning of the neural tube but also in IsO induction, 
showed by the loss of IsO in WNT1 homozygous mutants ([73]; reviewed in [74]). 
Shortly after the primary brain vesicles formation, Fibroblast Growth Factor 8 
(FGF8) secreted by IsO patterns the adjacent territories [71, 75–80]. Additional 
A/P patterning by extra-neurally secreted retinoic acid (RA) defines the meten-
cephalic and myelencephalic secondary hindbrain vesicles. The metencephalon 
expresses the homeobox gene Hoxa1, and formed the first hindbrain rhombomere 
(r1), where the FGF8 blocks the expression of other Hox genes. Next, the selec-
tive expression of negative regulators of the activated Ras–ERK pathway in r1 
stops the local action of FGF8 [81]. In parallel with the A/P patterning, whole 
neural tube is patterned also dorsoventrally (D/V). The main ventralizing fac-
tor is Sonic Hedgehog (SHH), which by e9 is produced in the floor plate of the 
metencephalon [15, 74, 82, 83] and secreted into the neural tube’s lumen, which at 
this level becomes the 4th ventricle. Consequently, the alar plate of the r1 territory 
Figure 2. 
Timing and the aligned stages in mouse and human cerebellar development. Embryonic days in mouse (e) and 
human (E). GW-gestational weeks. NE- neuroepithelium (light blue). The cerebellar ventricular zone (VZ) 
(blue) is the origin of the inhibitory neurons and glial cells. Inhibitory neurons (green) are the Purkinje cells 
(PC), Golgi, basket and stellate cells, and the inhibitory neurons in the deep cerebellar nuclei (I-DCN). The 
rhombic lip (RL) (Lila) is the origin of the excitatory neurons in the cortex (Granule cells (GC) and unipolar 
brush cells (UBC) and in the DCN (E-DCN). Long-lasting progenitor stages for the GC progenitors (GCP-
violet), and inhibitory interneuron and glial progenitors (INP and GP, blue). Long-lasting maturation of 
inhibitory neurons (light green) and of excitatory neurons (light pink-orange), and gliogenesis (gray) stages.
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is patterned into the cerebellar domain (anlagen) (Figure 3), while anteriorly 
situated territory becomes the tectum domain, posteriorly, the r2 domain, and 
ventrally, the pons domain.
Between e9 and e12.5 and, the cerebellar neuroepithelium undergoes morpho-
logical changes: the midline remains as a single cell layer and forms the roof plate, 
while each lateral part forms two primary proliferative zones, known as the origins 
of the neural populations in the mouse cerebellum: the cerebellar ventricular zone 
(VZ) and rhombic lip (RL) (Figures 2 and 3) [30]. By e10, the roof plate becomes 
the second cerebellar organizer center and secretes factors belonging (TGF)-β 
family, such as the bone morphogenetic proteins (BMPs), the most important 
dorsalizing factors in the cerebellum, and gradually transforms into the choroid 
plexus epithelium (ChPe). By e12.5, ChPe additionally produces SHH. Genetic 
fate mapping proved that the morphogens secreted by IsO, roof plate and floor 
plate define the cerebellar domains which, in addition to the hindbrain restricted 
Figure 3. 
Stages and distribution of cell populations in mouse early cerebellar development. Formation and 
differentiation of the cerebellar populations from embryonic day (e) 8 to e16, when all the neuronal 
populations or their long-lasting progenitors are formed. (A) Between e8 and 12, in the dorsal part of the first 
rhombomere (r1) of the hindbrain neural tube, the cerebellar ventricular zone (CVZ) (light blue) forms at 
e9–10, due to the dorsal FGF8 signal and ventral SHH signal, while the rhombic lip (RL) forms at after e10, 
being visible at the border between the CVZ and the roof plate (RP) (light Lila), due to the BMP signaling 
from the RP, which forms the choroid plexus epithelium (ChPe) (red). (B) Between e12 and 16, different 
progenitors arrive in the subventricular zone (SVZ) and mantle zone (MZ) of the neural tube. At e12–14, the 
Ptf1+ ventricular zone (VZ) of the CVZ primary domain contains the Olig2+ and the Gbx1+ subdomains, 
which generate the Purkinje cell progenitors (PCP) and the interneuron progenitors (INP, blue) domains, 
respectively, while the first postmitotic Purkinje cells (PC) already exit the SVZ. The VZ in RL contains 
Atoh1+ progenitors, which gradually form progenitors of the excitatory neurons in SVZ. They generate first 
the excitatory neurons for the deep cerebellar nuclei (E-DCN) and at later time points (e14–16), they start to 
generate the unipolar brush cells (UPC). The RL generates also the progenitors of the granule cells progenitors 
(GCP-violet), which migrate in waves in the MZ close to the pia mater (PM). In the CVZ, cells representing 
a subpopulation of the INP domain migrates in the MZ and join the E-DCN in a nuclear transitory zone 
(NTZ), where they start to differentiate into the inhibitory neurons of the DCN (I-DCN).
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expression of Gbx2, show the differential expression of two basic-helix–loop–helix 
(bHLH) transcription factors: Pancreatic transcription factor 1 (Ptf1) specifies 
the VZ domain and Atonal homolog 1 (Atoh1, also called Math1), specifies the RL 
progenitor domain [15, 58, 61, 84, 85].
Each cerebellar progenitor zone forms subdomains with their own spatial and 
temporal identities, which produce specific neuronal subtypes. VZ-derived progeni-
tors give rise to all GABAergic neurons and glial cells of the cerebellum. VZ-derived 
neurogenesis starts at e10.5 and continues untill e17 in mouse. Before the neurogen-
esis starts (~e9), the VZ progenitor domain corresponds to the neuroepithelial cells 
localized in the VZ of the r1 neural tube (Figure 3). Most of the earliest Ptf1a + pro-
genitors upregulate Kirrel2/Neph3 and oligodendrocyte-specific bHLH gene 
Olig2 expression [82, 86], while a small proportion in the early rostral VZ express 
homeodomain-containing transcription factor gene Gsx1. As the neural tube grows, 
the neuroepithelial cells gradually transform into radial glial progenitors and a sub-
ventricular zone appears evident in the VZ domain (SVZvz in Figure 3). Ptfa1+ and 
Olig2+ radial glial cells start to express Lhx1, Lhx5 and Skor2, and become Purkinje 
cell progenitors, located in the SVZvz, which gradually express Neurogenin 1 and 2, 
start neurogenesis and migrate from the SVZvz. Ptfa1+ and Gbx1+ radial glial cells 
gradually commit to inhibitory interneuron and glial progenitors. The interneuron 
progenitors express Lhx1, Lhx5 and Pax2. By e14.5, they become predominant in 
the SVZvz [87] and soon after start to migrate out of the SVZvz and form transient 
amplifying progenitor pools. Once all the neurons and transit amplifying progeni-
tors exit the SVZvz, the remaining radial glial cells differentiate into Bergmann glia. 
The VZ-derived transit amplifying progenitors generate inhibitory interneurons, 
astrocytes and oligodendrocytes [58].
The neuroepithelium of the RL gives rise to all glutamatergic neurons in the 
cerebellum (Figures 2 and 3), but also to extracerebellar neurons such as the 
pontine neurons [66, 70]. RL Atoh1+ neuroepithelial cells situated between the roof 
plate and the VZ domain start their proliferation after the adjacent VZ progenitors 
(~e10). Also the RL neuroepithelial cells gradually acquire a radial glial phenotype 
and are patterned in subdomains, which express the paired box gene Pax6 in com-
bination with the zinc finger genes Zic and the homeobox gene Meis. First, Pax6 and 
Meis2 expressing progenitors commit to neurogenesis, when they gradually express 
Tbr2 and Tbr1 and generate the glutamatergic neurons in DCN. Later, the remain-
ing RL progenitors co-expressing Pax6, Meis1, Zic1/2 and Barhl1 commit to granule 
cell progenitors, in parallel with the unipolar brush cell progenitors, which upregu-
late the Tbr2 expression, downregulate Pax6 expression and become  unipolar brush 
cells [15, 88].
The cerebellar proliferative zones in human embryos have been only recently 
investigated. The human cerebellar VZ (gradually forming the SVZvz) undergoes 
massive expansion which covers the second month (E30–56), afterwards extin-
guishing its proliferative potential and remaining as a single cell layer. Conversely, 
the RL germinal zone remains small during the peak expansion of the VZ progeni-
tors, but starts a significant expansion at around gestational week (GW) 11, when it 
forms the SVZRL, which persists long after birth [59, 60].
GABAergic phenotypes. Cerebellar inhibitory neurons, including Purkinje cells 
and interneurons (Golgi, stellate, basket and inhibitory neurons of the DCN) 
originate from different subdomains in cerebellar VZ (Ptf1a+), in different waves 
(Figures 2 and 3). Purkinje cell progenitors (expressing Skor2, Lhx1/5 and Corl2) 
gradually express Neurog1/2 and start neurogenesis, which in mouse is completed 
at e12.5. Once in the postmitotic stage, Purkinje cells start a short distance radial 
migration alongside the radial glial processes toward the mantle zone where they 
stack in a transient multilayered structure named the Purkinje cell plate and 
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gradually express markers such as Purkinje cell protein 2 (Pcp2, named also L7), 
Pcp4 and Calbindin 1 (Calb1) [15, 64]. In postnatal stages, due to extensive cerebel-
lar expansion, multilayered Purkinje cells gradually form a monolayer while each 
neuron starts the development of its characteristic extensive and flattened dendritic 
arbor and the expression of mature markers synaptic markers [30, 58, 89].
In humans, all Purkinje cells are generated before the 8th GW, which places them 
among the earliest-born central neurons. They start to migrate at E44 outwards 
from the VZ along radial glial projections to the pial surface. A broad Purkinje 
cell multilayer extending in the mantle zone is evident between the GW 10 and 13 
GW, while a monolayer distribution is achieved by GW 20–24 (Figure 2). Human 
Purkinje cells start to develop their characteristic extensive and flattened dendritic 
arbors and long axons in the early fetal stages, their final maturation being achieved 
postnatally, in a 6-fold longer period than in mice [59, 60, 90, 91].
Contrary to the Purkinje cells, which are postmitotic already into the cerebellar 
SVZvz, the Gbx1+ progenitors expressing the paired homeobox gene Pax2 migrate 
in several waves from the SVZvz to the mantle zone, where they start to express the 
neurogenic genes Neurog1 or Ascl1 and differentiate into Pax2+ interneurons. In the 
first wave (from ~e10.5), the interneuron progenitors migrate to the rostral end of 
the cerebellar anlage in a Nuclear Transitory Zone (NTZ), which is transient zone 
for the DCN assembly [15]. After the progenitors settle near the already established 
excitatory neurons, they produce the inhibitory interneurons of the DCN. In 
later stages of development, NTZ is gradually organized into distinct DCN. In the 
second wave (from ~e13.5), the interneuron progenitors migrate to the Purkinje cell 
multilayer, continue their migration in the developing white matter and postnatally 
reach the developing granular layer where they generate postmitotic Golgi cells. At 
later stages, interneuron progenitors migrate radially in the white matter, continue 
to proliferate in a transit amplifying center and eventually generate the stellate and 
basket cells in the ML [78, 92]. In parallel with the late interneurons progenitors, 
the progenitors of astrocytes and oligodendrocytes continue to proliferate in the 
developing white matter (Figure 2).
Glutamatergic cerebellar neurons (excitatory neurons in DCN, granule cells 
and unipolar brush cells) originate from different subdomains of the RL, in differ-
ent waves (Figures 2 and 3). The first cells leaving from the RL are the newborn 
excitatory neurons in DCN. Next, the granule cell progenitors migrate in waves 
out of the RL, where they continue the proliferation. In the first wave (e10.5–12.5), 
discrete subpopulations of rostrally situated Atoh1+ cells gradually upregulate 
Pax6, Meis2, Lhx9 Tbr2 and Tbr1 and become newborn glutamatergic neurons, 
which migrate rostrally and tangentially to the NTZ [15, 88, 93]. The allocation of a 
temporal framework of different DCN components is accompanied by a character-
ized sequence of transcriptional maturation that results in the first born neurons for 
the lateral nucleus (projecting to midbrain and thalamus), followed by neurons for 
the medial (fastigial) group.
The second wave covers middle to late embryonic stages, when Pax6+ granule 
cell progenitors leave the RL, migrate out toward the pial surface and undergo a 
prolonged expansion in a secondary germinal zone, or a second transit amplifying 
center, named the external granular layer (EGL) [64]. Granule cell progenitors retain 
the expression of Atoh1 and migrate into the mantle zone where they express Tbr2 
and continue to proliferate to form the EGL [88]. During the early postnatal period, 
multiple mitogenic pathways expand the EGL. Peak EGL proliferation occurs around 
p7 and is complete by p15 (Figure 2). The main mitogen is the SHH, secreted by the 
underlying Purkinje cells [94], but also Jag1, a ligand the Notch2, acts locally in the 
EGL [95]. Exponential granule cell proliferation in the EGL drives cerebellar growth 
and foliation [96]. BMP4 and WNT3 secreted by the ChPe promote cell-cycle exit and 
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neurogenesis [15]. The postmitotic granule cells downregulate Atoh1 and upregulate 
NeuroD1 [15]. Newborn granule cells migrate tangentially within the EGL and then 
exit the EGL migrating radially inwardly along Bergmann glial fibers, trailing a long 
T-shaped axon behind, interact with the flat, elaborate dendrites of Purkinje cells and 
form the parallel fibers in ML. Migrating granule cells settle below the developing PL 
to form the internal granule layer (IGL, corresponding to the adult GL), achieving 
the final laminar arrangement of the mature cerebellum, from where they extend 
dendrites to form synapses with mossy fiber afferent axons [15, 58].
Unipolar brush cell differentiation parallels the granule cell progenitor waves 
(Figure 2). Unipolar brush cells are born starting with e13.4, while continuing to 
p0–1. Progenitors of the unipolar brush cells express Wnt1 early in development 
(e10.5–13.5), but this expression is downregulated before they migrate from the 
RL. The newly generated neurons remain in the RL for an additional 1–2 days, after 
which they exit RL and migrate dorsally through the white matter to their final 
destination. Most unipolar brush cells reach the IGL by p10, several days before 
granule cell neurogenesis is complete. Their final maturation occurs between p2 and 
p28, which seems to coincide with the establishment of the first synaptic contacts 
with external mossy fibers [15, 27, 88].
3.2 Coordinated formation of the cerebellar circuits
The successful construction of the neuronal circuitry relies on the coordinated 
generation of functionally opposed neurons. Accordingly, the differentiation 
programs of cerebellar excitatory and inhibitory neurons are interdependent and 
defined as the coordinated integration of the VZ and RL-derived lineages in local 
circuits, in both the cortex and DCN. For the DCN, the cell fate of the excitatory 
neurons appears determined at the RL, in a temporal pattern, while the interneuron 
progenitors migrate, differentiate and integrate in the NTZ after receiving local 
signals from the excitatory neurons.
Purkinje cells have a remarkable capacity to regulate developmental events by 
sending SHH signals bi-directionally. Starting at e16.5 and continuing through-
out adulthood, SHH expression in cerebellum is restricted to Purkinje cells and 
Bergmann glia [97]. Dendritic-derived SHH drives the granule progenitor cell 
proliferation, while axon-derived SHH disseminates to the neonatal white matter 
and contributes to the expansion of the VZ-derived progenitors for the late-born 
interneurons and glial cells during the postnatal period [98]. Additionally, Purkinje 
cells are critical for the terminal differentiation and morphogenesis of the inter-
neurons in the ML, the basket and stellate cells. On the other side, signaling from 
differentiating granule cells influences the planarity and the elaborate branching 
pattern of the Purkinje cell dendritic tree, which occurs from p5 to p15 [99, 100]. 
Additionally, the dendritic differentiation of the interneurons in ML is sensitive to 
the granule cell-derived inputs, including BDNF signaling [15].
In the third trimester and postnatally, human cerebellum undergoes its major 
growth, primarily due to the prolonged expansion of the granule cell progenitors. 
By 10–11 GW, streams of cells which form the external GL (EGL) were observed 
along the pial surface connecting to the RL. Due to extensive EGL proliferation, 
human cerebellum increases 5 fold in size between GW 24–40 [90]. Differentiation 
and maturation of the human cerebellar neurons progress mainly as in the mouse, 
but there are some species-specific features. Foliation correlates with EGL prolif-
eration and increases dramatically between GW 20–32, as the cerebellum rapidly 
increases in size and volume. The formation of the Purkinje cell monolayer coin-
cides with the peak of EGL proliferation [89, 90]. The human cerebellar cortex still 
has a prominent EGL at birth. EGL gradually decreases in thickness as a result of 
15
Human Pluripotent Stem Cell-Derived Cerebellar Neurons: From Development to Modeling…
DOI: http://dx.doi.org/10.5772/intechopen.96653
migration of granule cells into the internal GL. By the end of the second postnatal 
year, EGL is depleted while the thickness of the molecular layer and the length of 
the PL increase, concomitant with the increasing cerebellar volume [89, 90]. To 
date, there are few studies about the development of the human interneurons, both 
inhibitory and excitatory, which represent a minority comparing to the granule 
cells, but with a major role in the maturation of Purkinje cells and circuit formation 
[15, 34, 58, 91, 101].
In addition, the single-cell sequencing techniques have been applied for analyz-
ing different stages of mouse cerebellar development [62, 102]. Carter et al. [62] 
performed single-cell RNA-sequencing and unbiased classification of around 40 
thousand murine cerebellar cells from eight embryonic samples (at e10-e17) and 4 
postnatal samples (at p0, p4, p7 and p10). Such approach allows for a more compre-
hensive detailing of the transcriptional and cellular heterogeneity among lineages 
of interest and can provide a valuable resource for answering further questions 
related to cerebellar development and diseases. In a similar study, Peng et al. [102] 
analyzed around 20 thousand cells from mouse postnatal cerebella and looked in 
addition to the dynamics of interneuron differentiation but also mitochondrial 
markers and ataxia risk genes. In a complementary approach, gene expression in the 
postnatal stages of mouse cerebellar development were analyzed by Buchholtz et al. 
[28] in Purkinje cell populations selected from mice expressing a Egfp-Pcp2 reporter 
gene. Again, the dynamics of different pathways of mitochondrial and autophagy 
genes correlated with the developmental stages of Purkinje cells, which suggest 
their implication in several neurodevelopmental diseases.
3.3  From development of the cerebellum to the optimization of the human PSC 
differentiation protocols
There are several steps to be considered for the cerebellar protocols, which practi-
cally cover all the developmental stages: from neural induction and dorsal hindbrain 
patterning to the patterning and proliferation of the VZ-like and RL-like progeni-
tors, to the neurogenesis of the selected progenitors, and lastly to the maturation 
of the neurons and the formation of the neuronal circuits. Are the previously used 
neural induction and early patterning conditions (in both 2D and 3D approaches) 
optimal for the generation of progenitors similar to the ones in the dorsal r1 in the 
neurula stage, which represent the origin of the neurons making the cerebellum? Are 
the previously used conditions optimal for the uniform generation of early VZ and 
RL progenitors? Which factors and what timing would be necessary for a uniform 
patterning towards VZ or RL subpopulations? Which conditions would be efficient 
to produce a uniform neurogenesis from different progenitors? What would the 
defined conditions for the neuronal maturation be? How can the neuronal matura-
tion be faster? How can other neuronal subtypes, such as the interneurons in the 
cerebellar cortex and in the DCN, be generated uniformly and efficiently?
Some recent strategies were successful for the optimization of the protocols for 
the cerebral neurons and cerebral organoids. It remains to be checked whether these 
strategies can be extrapolated for the cerebellar cultures. Again, the solutions may 
come from the development principles. The main traiectories that could be followed 
from the human iPSC to the neuronal cell types contained in the cerebellum are 
outlooked in Figure 4 and detailed in the following paragraphs.
Improving neural induction and hindbrain patterning. The first step for all the 
protocols regarding the neural differentiation of human PSCs implies the removing 
of the pluripotent cell proliferation factors, such as FGF2 and TGFβ. The additional 
use of several inhibitors such as BMP/Activin/TGFβ pathway inhibitors, alone (such 
as Noggin) or in combination (dual-SMAD inhibition by small molecules such as 
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dorsomorphin or LDN and SB431542) [56], significantly increased the yield of 
neural induction in human PSCs cultured in serum-free medium, both in 2D and 
3D systems [40]. Shortly after neural induction, human PAX6+ neuroepithelial 
cells acquire a primitive anterior identity, expressing OTX2, but no more caudal 
markers, like EN1, GBX2, or HOX genes [56, 103]. However, this anterior phenotype 
is transient and, depending on the presence of added or endogenously secreted 
morphogens such as WNTs, FGFs, and RA, neuroepithelial cells take on a definitive 
regional identity [41, 104–106].
Some previous protocols used FGF2 for amplifying the neuroepithelial popula-
tion and showed that, although an anterior phenotype is kept for a few passages 
in the presence of FGF2, longer exposure gradually patterns human progeni-
tors toward midbrain and hindbrain fates [105, 107, 108]. FGF2 was used by 
Muguruma et al. [50] for inducing a brought midbrain-hindbrain patterning, 
including the IsO-like cells, in 3D spontaneously differentiating human PSCs in 
serum-free medium, for a time approximating the MHB formation in human 
embryos. However, the reproducibility of this protocol is limited and the effi-
ciency of the neural induction and pattering was not investigated, many cells in 
the 3D clusters could present a more anterior phenotype (and maybe non-neural 
phenotypes). Watson et al. [52] proposed the parallel neural induction and 
hindbrain patterning by using FGF2 in combination with the SMAD inhibitor 
SB431542 for around 20 days. Even though it showed an increased expression in 
hindbrain and cerebellar markers, yet the efficiency and the selectivity of this 
approach was not reported.
Figure 4. 
In vitro trajectories from human induced pluripotent stem cells to cerebellar neurons by combining the 
differentiation protocols and the developmental principles. The differentiation conditions for some stages 
(meaning the combination of extrinsic factors, their concentration and time of action in the protocol) are 
previously established. However, for several steps, it remains to be established which treatments are necessary 
for patterning and proliferation of progenitor subpopulation in VZ and RL and in the secondary proliferation 
domains. Some factors which are known to act in the mouse cerebellar development could work also for the 
patterning and proliferation of human progenitor cells, but many question marks remain. These questions 
address both the treatments and the specific markers for subpopulation of progenitor cells and neurons.
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The implementation of WNT signaling was shown to increase the midbrain and 
hindbrain patterning and reduce the spontaneous forebrain patterning in human 
PSC-derived neural cultures [28, 41, 54, 109, 110]. In Kirkeby et al. [41] and Kirkeby 
et al. [110], neural induction with dual-SMAD inhibition and pattering were 
applied in parallel for 9 days. The GSK3 inhibitor CHIR99021 was used at 1–2 μM 
concentration for patterning the anterior r1 fate. Following this protocol with some 
modifications, Sundberg et al. [54] applied the neural induction and hindbrain pat-
terning by WNT in the same time, for 12 days, with noggin and 1.7 μM CHIR99021, 
while in a following study coming from the same group [28], neural induction and 
patterning with CHIR99021 1.5 μM was applied for only 4 days. In both studies, 
FGF8b (100 ng/ml) was added from day 4 to day 12 of differentiation, while FGF2 
applied at day 10–12 in Sundberg et al. [54] was excluded in the next protocol [28]. 
However, the resulted cell populations in both studies were not directly pheno-
typed, but after 16 or 32 days of differentiation, when they contained KIRREL2+ or 
THY1+ cells, respectively, which were selected by FACS. Further optimization for 
neural induction and hindbrain patterning requires a deeper investigation, includ-
ing negative markers for forebrain, midbrain, hindbrain (excepting the r1), and 
ventral markers (especially for the r1). The dorsal r1 cells should concomitantly and 
uniformly express GBX2 and EN1/2. Obviously, reporter lines for different genes 
expressed solely in r1, such as HOXA1, would be very useful tools.
In addition, a study using human hindbrain tissue from embryos at GW 5–7 
showed that the hindbrain neuroepithelial cells were stably expandable in FGF2 
and EGF conditions, but the short treatment with FGF8 and WNT (for 1 pas-
sage) hugely increased the expression of GBX2, EN1 and EN2 [111]. A deeper 
investigation of the human embryonic dorsal hindbrain tissue could provide 
hints for the optimization of the human PSC differentiation protocol toward 
cerebellar cells. The human embryonic hindbrain neuroepithelial cells can be 
further patterned in vitro by BMPs (BMP6, BMP7 and GDF7) and WNT3A to RL 
progenitors (ATOH1), which generated granule cells after transplantation into 
the rat cerebellum [111]. Some additional hints are revealed by the pattering of 
the human embryonic hindbrain tissue. ATOH1 was not expressed if FGF8 was 
added together with BMPs or if FGF2 and EGF were maintained, FGF signal-
ing appearing to counteract the BMP stimulation [111]. The same factors were 
applied for the RL patterning from human PSCs (reviewed in [40]). It appears 
clear that ATOH is not expressed by default, but only after BMP signaling, in 
spontaneous or directed differentiation approaches. Again, developing human 
PSC reporter lines for ATOH and a deeper phenotypic investigation, including 
negative markers such the ones express in vicinity of the RL, (e.g. in pons, tectum 
and neural crest), would be of great help. The same approach is necessary for the 
optimization of cerebellar VZ progenitors, which are favorized by FGFs and SHH 
treatments. It remains to be established which treatments with extrinsic factors 
(combination, concentration and time) are necessary for patterning and prolif-
eration of progenitor subpopulation in VZ and RL, as well as out of them, in the 
secondary proliferation domain, as long-term proliferative populations (such as 
granule progenitor cells, interneuron progenitor cells and glial progenitor cells). 
Some factors known to act in the mouse cerebellar development could work also 
for human progenitor cells, but many question marks remain. These questions 
address both the treatments and the specific markers for subpopulation of pro-
genitors and neurons (Figure 4).
Increasing maturation of the cerebellar neurons in defined conditions. One of the 
most consistent observations about human PSC-derived neurons is that they mature 
relatively slow and often incomplete (reviewed in [3]). An obvious reason is the 
time in culture: human PSC-derived Purkinje cells are usually kept in culture around 
Spinocerebellar Ataxia
18
4 months, while they need over 2 years for maturation in vivo. An important chal-
lenge is the long-term culture and maturation of human PSC-derived cerebellar 
neurons without the presence of mouse cell/tissue co-cultures. Mature phenotypes 
of PSC-derived Purkinje cells and granule cells have so far only been demonstrated 
in co-culture or, more convincingly, by transplantation of differentiated cells into 
mouse cerebellum. While some of the in vitro and transplantation procedures 
demonstrated the potential of the PSC-derived neurons to mature into functional 
cerebellar neurons, they also highlighted the need to better understand the factors 
that promote their maturation. Significant variability in the efficiency to obtain func-
tional Purkinje cells using different feeder cell sources was reported. For instance, 
feeder-free and co-culturing with rat granular progenitors failed to sustain Purkinje 
cell maturation and survival, while co-culture with rat cerebellar slices sustained 
Purkinje cells that nevertheless were devoided of any action potential or spontane-
ous post-synaptic currents. In contrast, co-culture with human fetal cerebellar slices 
resulted in electrophysiological active Purkinje cells [49], suggesting that human 
specific factors, as well as interactions with glial cells [112] are needed for proper 
maturation. The use of the co-culture system has limitations per se, feeder cells intro-
ducing inherent variability to the procedure [49]. A growing number of methods for 
reverse-engineering specific cellular micro-environments and the cells and molecules 
which constitute these [113] will definitely extend into the cerebellar field. It is likely 
that the combination of these technologies will help in elucidating key conditions for 
long-term survival and maturation of PSC-derived cerebellar neurons.
Another approach can come for the optimization of long-term cultures of cerebel-
lar organoid, in line with the extensively investigated field of cerebral organoids 
[39]. As shown in different previous reports, functional synaptic connections are 
necessary for maturation and activity of the human PSC-derived neurons, which 
include glia and target neurons, all of these could be provided in the same cerebellar 
organoid.
Again, one limitation for most of the human PSC-derived neurons, as for the 
human neurons in general, is the lack of transcriptomic signatures, to rigorously 
identify specific types of neurons and to compare their development across spe-
cies. A recent Metagene projection analysis of global gene expression patterns 
revealed that differentiating human PSC-derived Purkinje cells share classical and 
developmental gene expression signatures with developing mouse Purkinje cells. 
Remarkably, it revealed that the human PSC-derived Purkinje cells matured in 
co-culture for around two months are closest to late juvenile (p21) mouse Purkinje 
cells, suggesting that they are relatively mature. Gene expression profiling also 
identified human-specific genes in human PSC-derived Purkinje cells. Protein 
expression for one of these human-specific genes CD40LG, a tumor necrosis factor 
superfamily member, was confirmed in native human cerebellar tissue, arguing for 
the bona-fide nature of the human PSC-derived cerebellar neurons [28]. Obviously, 
the routine applications of the single-cell transcriptomics into the optimization 
steps of the human PSC-derived cerebellar differentiation protocols will hugely 
contribute to the progress in the field.
4. iPSC-derived models for cerebellar ataxias
The iPSC technology together with the cerebellar differentiation protocols offer 
the opportunity to indirectly generate and to directly study the most affected cells in 
patients with cerebellar ataxias, the cerebellar neurons. As schematically presented 
in Figure 5, somatic cells such as skin fibroblasts or white blood cells obtained from 
patients are reprogrammed into iPSCs, which can be theoretically differentiated 
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into any type of neurons. Ideally, the neuronal differentiation should address the 
most affected subpopulation in each disease, by following the existing protocols 
or optimized protocols in the desired direction (using development principles and 
combining efficient selection methods). Remarkably, for the inherited ataxias, the 
patient iPSC-derived neurons express the disease mutation in the authentic genetic 
background and cellular environment, which is not the case in the animal models.
The neuropathological events in hereditary cerebellar ataxias affect both 
cerebellar and extracerebellar territories. Nevertheless, degeneration and ultimate 
loss of cerebellar neurons is a neuropathological hallmark in cerebellar ataxias. The 
affected cerebellar neurons and the responsible genes for several cerebellar ataxias 
are presented in Table 2. Spinocerebellar ataxias (SCAs) are a family of over 40 
currently described late-onset dominant diseases, manifesting clinically at middle 
age and gradually progressing with neurodegeneration in cerebellum and other 
CNS areas, [136–139] while in other genetic ataxias, such as the autosomal recessive 
Friedreich ataxia (FRDA) and ataxia-telangiectasia (AT), the disease manifests a lot 
earlier and, in addition to the nervous system, extraneural territories are affected 
[137, 138]. FRDA is considered a multi-systemic condition, including central and 
peripheral neuropathies, diabetes and cardiomyopathy [140, 141].
In cerebellum, SCA1, SCA3 and FRDA involve mainly the DCN, especially the 
dentate nucleus, but also extracerebellar territories such as the Clarke’s column, which 
present with severe neuronal loss (reviewed in [142]). SCA2 predominantly affects 
the pontine nuclei, while the Purkinje cells and DCN seem to be secondarily affected. 
SCA31 is relatively restricted to the Purkinje cells. Although Purkinje cells are pre-
dominantly involved in SCA6, degeneration is evident also in the dentate nucleus and 
granule cells. Therefore, patients with SCA6 show more severe ataxia than those with 
SCA31. Several SCA subtypes have CAG repeat expansions in the coding region of 
different genes (http://www.scabase.eu/; [143–146]), resulting in PolyQ elongations 
in the respective proteins, the elongation size being correlated with the intensity 
of clinical manifestations. In other SCAs (SCA12, SCA31 and SCA36) or non-SCA 
monogenic ataxias, such as FRDA, the repeat expansion is intronic, but also in these 
diseases the cerebellar dysfunction is correlated with the elongation size [147].
Modeling these human genetic disorders in mice has reproduced to a certain 
extend the neuropathological aspects and has provided some insights into disease 
mechanisms. Many disease mechanisms that have been explored in mouse models 
are expected to be recapitulated in patient iPSC-derived neurons. However, some 
ataxias could not be modeled in mice using the same mutation as in the patients, 
suggestion that the human-specific environment is essential for the disease to 
Figure 5. 
From ataxia patients to neuronal disease models. Somatic cells from patients with cerebellar ataxias are 
reprogrammed into induced pluripotent stem (iPS) cells, which can be genetically modified in order to correct 
the mutation. Patient and control/corrected iPS cells can be differentiated into neurons that are relevant for the 
cerebellar diseases, such as Purkinje cells. Additional stress or forced aging can be equally applied to the patient 
and control/corrected neurons or their progenitors, in order to amplify the phenotypic differences resulted from 
the ataxia’s specific mutation.
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develop. Additional mechanistic understanding of the network of events produced 
by the mutation is crucial for the development of effective therapies, as none of the 
cerebellar ataxias is yet curable, treatable or preventable [143, 145, 147–149].
For modeling cerebellar ataxias, the iPSC-based models present three main 
advantages. First, most of cerebellar ataxias are monogenic diseases. Second, 
neurons bearing the mutation, which are not directly available from patients, can 
be generated in vitro from the patient iPSCs. Third, the human neurons generated 
in vitro seem to acquire a molecular profile close to the postnatal age in mouse, 
as in the previously mentioned Metagene analysis of key gene pathways, which 
showed that the human Purkinje cells generated in vitro have the closest molecular 
expression with the Purkinje cells in p21 mouse cerebellum [28]. As for many mouse 
models for cerebellar ataxias a disease phenotype was found close to this age, the in 
vitro generated human neurons are expected to behave similarly and to reveal the 



















ATXN 1, (CAG)39–83 
exon 8
Ataxin-1 —  [114, 115]
SCA2 PCs+++, 
DCN+++
ATXN2, (CAG)35–79 exon1 Ataxin-2 CNS [116, 117]
SCA3 PCs+, 
DCN+++





















TBP, (CAG)47–63 exon3 TBP — —


















FXN, (GAA)n, intron 1 Frataxin PNS, CNS [128–134]
A-T PCs+++, 
GCs+++
ATM, exon, truncating, 
splicing or missense 
mutation
ATM cerebellar [135]
PCs-Purkinje cells, GCs-granule cells, DCN-deep cerebellar nuclei, +++high ++ medium, +low.
Table 2. 
Affected cerebellar neurons and iPSC-derived models for different ataxias.
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However, as presented in Table 2, relatively few studies have succeeded in 
generating iPSC-based models for cerebellar ataxias. An additional important 
question for the iPSC-based models is to what extend the mutated gene is expressed 
in the neurons generated in vitro. The most vulnerable and affected cells are neuro-
nal subpopulations, most of them being located in cerebellum. From the reported 
iPSC-derived models, only a very few implemented the cerebellar differentia-
tion protocols, including the pathways for generating the specific cerebellar cells 
affected in disease.
A handful of studies published to date addressed iPSC models of PolyQ SCAs 
(such as SCA1, 2, 3, 6, 7 and 12), non-PolyQ SCAs (such as SCA36 and 42), and 
other ataxias (such as FRDA and A-T). Most of the iPSC-based models used a 
generic differentiation towards the neural lineage, as opposed to the generation of 
specific neuronal subtypes, and very few characterized the neuronal phenotypes. 
The only reported iPSC-derived models addressing the cerebellar neurons were for 
SCA6 [51], SCA42 [127] and A-T [135].
For SCA1 and SCA12, only the generation of patient-derived iPSCs were until 
now reported [114, 115, 119, 125]. Several other SCA models have already addressed 
the neural phenotypes. SCA2 was modeled by Xia et al. [116] and by Chuang et 
al. [117] using patient iPSC-derived neural progenitors and central neurons. No 
cerebellar protocol has yet addressed SCA2, in which both Purkinje cells PCs and 
DCN neurons are affected. Whereas patient and control fibroblasts showed com-
parable levels of expression of the disease-causing protein Ataxin-2, its expression 
was decreased in patient iPSC-derived neural stem cells, which survived shorter in 
cell culture. Chuang et al. [117] reported that SCA2 neurons exhibited a glutamate-
dependent disease phenotype, which are suppressed by anti-glutamate drugs and a 
calcium stabilizer treatment.
One of the first studies using the generation of neurons from patient iPSCs 
addressed to SCA3, also called Machado-Joseph disease (MJD) [118]. In this 
model, neuronal excitation by glutamate promoted an increase in intracellular 
calcium concentration and proteolysis of Ataxin-3, triggering its aggregation—a 
hallmark of the disease in patients. This intraneuronal aggregation, (which was 
also found to depend on sodium and potassium channel function, as well as 
on ionotropic and voltage-gated calcium channel function), was abolished by 
calpain inhibition, pointing to a key role of this protease in Ataxin-3 cleavage. 
Furthermore, intracellular aggregations were not observed in patient iPSCs, 
fibroblasts or iPSC-derived glial cells, providing a clue for the neuron-specific 
phenotype observed in SCA3 patients. Hansen et al. [120] differentiated the SCA3 
patient-derived iPSCs further into hindbrain neurons that expressed GBX2 and 
HOXA2. They reported that glutamate loading or calcium increase by ionomycin 
did not induce Ataxin-3 accumulation in these hindbrain neurons. It remains to 
be investigated whether this discrepancy comes from a difference in cell types or 
in the applied protocols. In another study [121], SCA3 iPSCs differentiated into 
NeuN-positive (postmitotic) neurons showed accumulation of Ataxin-3 in the 
absence of stress. The activation of autophagy by rapamycin was effective for deg-
radation of Ataxin-3, suggesting that autophagy could be a key for development 
of therapeutic treatments. Chuang et al. [117] reported that SCA3 iPSC-derived 
neurons again showed glutamate-dependent phenotypes, which were suppressed 
by anti-glutamate drugs. Ouyang et al. [122] applied gene editing techniques for 
the deletion of the expanded CAG in the ATXN3 gene in SCA3 patient-derived 
iPSCs, which were further characterized. Such corrected iPSCs will be useful for 
SCA3 isogenic models. However, no further studies have addressed SCA3 iPSC-
derived cerebellar neurons and a directed protocol for the DCN neurons, the most 
affected in SCA3, is not yet available.
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SCA6 is a very interesting case, first, by being one of the three diseases in which 
patient iPSC-derived cerebellar neurons were generated to date, and second, 
because of the bicistronic nature of the affected gene, CACNA1A. It encodes the 
α1A subunit of P/Q-type voltage-dependent calcium channel Cav2.1, and the 
α1ACT, with an identical sequence with the PolyQ bearing C-terminal segment 
of the longest isoform of α1A [150]. In addition, the gene is expressed mainly in 
neurons, contrary to the other ataxia-related genes, that are ubiquitous expressed. 
Utilizing the differentiation method for the cerebellar neurons [50], Ishida et al. 
[51] differentiated Purkinje cells from iPSCs derived from hetero- and homozy-
gous SCA6 patients [51]. They found that SCA6-derived Purkinje cells exhibit 
decreased expression of α1ACT and its target molecules, TAF1 and BTG1. They 
further constructed a disease model in which SCA6 patient-derived Purkinje cells 
specifically degenerate by depletion of the thyroid hormone triiodothyronine (T3), 
which is necessary in late stages of maturation. Bavassano et al. [107] differentiated 
SCA6 patient-derived iPSCs into neurons expressing Cav2.1 and α1ACT, using the 
same differentiation and stress model as for the SCA3 [118]. The glutamate loading 
decreased the viability of SCA6 neurons, pointing toward a common pathway of 
stress response in PolyQ SCAs. In addition, SCA6 neurons showed differences in the 
expression of several genes previously reported to depend on the transcriptional 
regulation by the α1ACT, and showed no differences in the electric response of the 
Cav2.1 channel. Recent high-throughput investigations in the mouse and human 
cerebellum revealed complex functions of α1ACT [26] and further studies are 
expected to clarify the role of the mutated α1ACT in cerebellar neurons, especially 
in Purkinje cells.
For SCA7, in which cerebellar and retinal cells are degenerated [151], Luo 
et al. [123] reported the generation of iPSCs and neurons from a SCA7 patient, 
but did not characterize the neuronal phenotype and the disease phenotype. 
Ward et al. [124] generated SCA7 patient-derived iPSCs and their isogenic lines 
transduced with either normal or expanded ATXN7. They reported that SCA7 
iPSC-derived neural progenitors exhibit altered metabolism and mitochondrial 
dysfunction.
SCA36 and SCA42 are non PolyQ autosomal dominant diseases, affecting the 
cerebellar neurons and other neurons. Matsuzono et al. [126] generated motor 
neurons from the patient-derived iPSCs and recapitulated an increase in RNA 
foci-positive cells that can be markedly suppressed by treatment of antisense 
oligonucleotide. SCA42 is caused by a mutation in CACNA1G, which encodes T-type 
voltage-dependent calcium channel Cav3.1 [127]. In addition to identifying the 
affected gene, [127] reported a model disease for which patient-derived iPSCs were 
differentiated into Purkinje cells. The SCA42-derived Purkinje cells would provide 
a useful tool for further phenotype analysis of the mutated CAV3.1, for which the 
investigation was till now limited to the HEK293 cell line.
For the FRDA, a pioneering work revealed that abnormal expansion of GAA 
repeats led to upregulation of the DNA mismatch repair protein MSH2 in FRDA 
patient-derived iPSCs [130]. They reported that the functional inhibition of MSH2 
by shRNA suppresses the repeat expansion. They further reported an inhibitor of 
histone deacetylase HDACi 109 increased the expression of FXN gene and Frataxin 
protein, pointing to the involvement of histone H3 lysine 9 in FXN expression. 
Polak et al. [131] also focused on epigenetic modifications in FRDA-derived iPSCs 
and performed drug evaluations. They found that an inhibitor of lysine-specific 
demethylation enzyme 1 (called Parnate or Tranylcypromine), and the HDAC 
inhibitor sodium butyrate have transient effects on decreasing the repeats and 
increasing FXN gene expression. Bird et al. [132] also reported a decrease in 
Frataxin expression in neurons differentiated from FRDA iPSCs, but could not 
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detect abnormality in mitochondrial functions. Hick et al. [133] reported decreased 
expression of FXN and Frataxin, a decrease in mitochondrial membrane potential 
and degeneration of mitochondria in FRDA IPSC-derived neurons. Eigentler 
et al. [128] showed a cell-specific decrease of frataxin in disease-vulnerable FRDA 
iPSC-derived peripheral neurons. Lai et al. [129] and Mazzara et al. [134] gener-
ated FRDA isogenic lines. Mazzara et al. [134] demonstrated that the entire intron 
1 removal, and not solely the elongation, was necessary for the recovery of the 
FXN expression level in peripheral sensory neurons. Although several studies have 
provided insights into the pathogenesis of FRDA in cardiomyocytes and peripheral 
neurons, additional work is required to elucidate the role of Frataxin in other 
affected cell types, such as the neurons of the DCN.
For the A-T is caused by several mutations in the ATM gene [152], Nayler 
et al. [135] differentiated A-T patient-derived iPSCs into cerebellar neurons and 
performed RNA sequencing analysis with them. Remarkably, they found that the 
generated neurons acquired properties of the cerebellum at GW 22 and exhibited 
disrupted gene regulatory networks related to synaptic vesicle dynamics and 
 oxidative stress.
5. Strategies for optimizing the neuronal models of cerebellar ataxias
Of particular interest in future research in the cerebellar ataxias is the compari-
son between affected and unaffected neuronal types, in order to identify particular 
characteristics that render specific neuronal populations vulnerable to a genetic 
insult which is ubiquitously presented. One of the most crucial needs is to establish 
a reliable and consistent disease phenotype in a relevant cell population, and those 
cell types to be generated in relatively large quantities in vitro [153].
Differentiation into specific and mature neurons that are the disease targets, 
such as Purkinje cells for several SCAs, or solely DCN neurons for some ataxias, 
or both of them for the most of SCAs (Table 2), will enable the construction 
of more reliable disease models [154]. However, the suitability of iPSC-derived 
neurons for modeling late-onset conditions remains controversial, particularly 
given the immature, fetal-like phenotypes of the neurons generated from 
these cells.
Remarkably, in contrast to the immature morphology observed for human PSC-
derived Purkinje cells, a recent bioinformatics analysis of their gene expression and 
developing showed that they most closely resembled late juvenile p21 mouse expres-
sion mouse Purkinje cells, when most of the cerebellar disease phenotypes in several 
animal models start to manifest. This finding suggests that the Purkinje cells are 
among the most mature human PSC-derived central neurons analyzed to date. This 
approach also underscores the utility of transcriptomic analysis for analyzing the 
maturation of human PSC-derived neurons and validates the use of hPSC-neurons 
for modeling cerebellar ataxias.
Still, it is possible that the disease phenotypes of adult-onset conditions, as the 
most of genetic SCAs are, may never be fully recapitulated under 2D cell culture 
conditions, even with directed protocols and optimized maturation. Generation 
of 3D cerebellar-like tissues as the cerebellar organoids may allow to increasing the 
neuronal maturation in vitro. The next generation or organoids or “assembloids”, 
which will allow the proper combination of different cell types, including vascular-
ization, can offer a good perspective but also limitations by increased heterogeneity. 
The multiomics approaches at single-cell level can definitely contribute to under-




Another way to model the late-onset diseases is the addition of neural stressors, 
such as reactive oxygen species, pro-inflammatory factors, and toxins or forced 
aging, as schematically presented in Figure 5. These approaches were already used 
for modeling several SCAs or other neurologic diseases [153, 155–157]. However, 
in an ideal situation, these stressors should only exacerbate the disease phenotype, 
which can be evident in a good model solely by the expression of the mutation in the 
disease-relevant cells. Another approach is to genetically manipulate the system for 
forcing the aging, such as by overexpression of progerin in neural progenitors. By 
this approach, the disease phenotype is expected to manifest in vitro in earlier stages 
of neuronal maturation [155, 156] (reviewed in [158]).
On the other side, recent evidence from cell and animal models indicates 
that abnormalities in early Purkinje cell development may contribute to the 
pathogenesis of the ataxias Purkinje cell developmental abnormalities are 
clearly evident in a wide range of ataxic mouse mutants, including models of 
the degenerative SCAs [26]. The observed Purkinje cell developmental defects 
commonly include impaired dendritic arborization, resulting in synaptic 
deficits affecting CF and PF connections and ultimately altering Purkinje cell 
physiology. Similar impairments in Purkinje cell dendritogenesis and synapse 
formation have been described in mouse models of SCA5, and in cell and 
mouse models of SCA14, SCA1, SCA3 and SCA5. Given the increasing evidence 
for Purkinje cell developmental abnormalities in cerebellar ataxias, it seems 
likely that iPSC-derived models, which are capable of recapitulating early 
developmental events in vitro, will be invaluable in unraveling the pathogenic 
complexities of these conditions. It will be important to better understand the 
underlying—likely common—molecular mechanisms, by which mutations in 
distinct genes cause abnormal Purkinje cell development and function [159]. 
These could offer attractive future therapeutic targets to alleviate motor dys-
function in cerebellar ataxia.
Another limitation in the field of modeling cerebellar ataxias is that most 
of the studies implemeted the production of iPSCs from a few patients. On one 
hand, addressing to larger patient cohorts may allow to identifying more accurate 
phenotypes. On the other hand, for investigating the pathological function of a 
mutation, the ideal situation is to compare the cells bearing the mutation with 
control cells with an identical genetic background. The rapid development of 
CRISPR/Cas9-mediated genome editing is likely to result in significant advances 
in the field, allowing the correction of disease-causing mutations into iPSCs, 
which can then be used to create paired isogenic lines to produce better disease 
models in which far less patient-derived cell lines will be necessary [160]. This 
was already performed even for the ‘difficult to correct’ elongations, like in SCA3, 
SCA7, it is expected in the near future to constitute ‘the norm’ for all iPSC-derived 
disease models.
The establishment of efficient, reproducible cellular models of cerebel-
lar dysfunction and degeneration will be important not only in elucidating the 
molecular basis of these diseases, but also in the development of effective therapies. 
Establishment of special cell cultures, such as Purkinje cells from patients with 
cerebellar ataxia, provides opportunities to screen for drugs that may correct the 
observed disease phenotypes. These cell cultures can be combined with stressors 
capable of eliciting phenotypes in late-onset conditions and genotypic modifiers 
of disease progression and drug response. In addition, these cerebellar cell cultures 
may be used for toxicity screens, to assess the effects of novel compounds on 
relevant cell types, or for differentiation screens, to identify compounds capable 
of enhancing self-renewal, maturation or survival of specific cerebellar cells 
(Figure 5).
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6. Final remarks
Recent technologies for producing iPSCs from patients combined with the dif-
ferentiation of PSCs into neural cells and the self-organizing 3D neural tissues have 
provided a new way to experimentally investigate the developmental and disease 
mechanisms of the human brain. While several challenges have hindered the gen-
eration of cerebellar neurons in vitro, starting from human PSCs, some important 
steps have been made. These protocols, combined with the patient-derived iPSCs, 
have been further applied for the investigation of several cerebellar diseases. In 
addition to the “classical” protocols aimed to generate specific types of neurons in 
two-dimensional (2D) cell cultures, recent progress has been made in culturing cells 
in three-dimensional (3D) structures, which may better reproduce the tissue orga-
nization and complexity in vivo, such as the PSC-derived brain organoids. Despite 
promising results, a number of issues remain to be addressed before the iPSC-based 
models to be widely adopted. Generation of the disease-relevant cerebellar cells 
and tissue in vitro remains a challenge, requiring a precise understanding of the 
complex molecular events during the development of each neuronal subtype, and 
an accurate set of markers by which to identify and characterize the generated cells. 
The 3D brain models in general and the 3D cerebellar models in particular still wait 
for improvements, including a better cellular characterization and an increased 
reliability, in order to contribute to better disease models.
However, human PSC-based models offer distinct advantages for the study of 
cerebellar ataxias. Cerebellar neuronal models are likely to provide valuable insights 
into the selective vulnerability of distinct neuronal subtypes, particularly the 
Purkinje cells. More directed and/or complex approaches will allow for the genera-
tion of accurate, disease-relevant models for the study of the molecular mechanisms 
underlying cerebellar ataxias, and the development of the long-awaited therapies.
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